Aarti Drugs fundamental analysis

AARTIDRUGS

381.4

4.25 (1.13%)
Last updated on 10 Feb, 2026 | 14:13 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Aarti Drugs Fundamentals

P/E Ratio

16.97

P/B Ratio

2.28

Div. Yield

0.27

Sector P/E

64.71

Sector P/B

1.4

Sec. Div. Yield

0.57

Aarti Drugs Fundamentals is currently trading with a P/E Ratio of 16.97, compared to the sector average of 64.71. Its P/B Ratio stands at 2.28, while the sector’s is 1.4. In terms of returns, the stock offers a Dividend Yield of 0.27%, which is than the sector’s 0.57%.

Aarti Drugs Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Moderate

  • quality_check
    Quality

    Average

  • quality_check
    Management

    Good

On its scorecard, Aarti Drugs reflects: Price – Attractive, Growth – Moderate, Quality – Average, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.